Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-21 Sale |
2025-03-24 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
10,031 | $41.23 | $413,578 | 339,769 (Indirect Direct) |
View |
| 2025-03-11 Sale |
2025-03-12 7:05 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
14,435 | $42.7 | $616,349 | 309,550 (Indirect Direct) |
View |
| 2025-02-19 Sale |
2025-02-21 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
18,360 | $55.2 | $1,013,564 | 257,235 (Indirect Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
18,568 | $54.21 | $1,006,580 | 288,845 (Indirect Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $55.1 | $826,565 | 267,162 (Indirect Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $55.62 | $1,668,678 | 282,162 (Indirect Direct) |
View |
| 2024-10-14 Sale |
2024-10-15 6:00 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
4,293 | $46.28 | $198,680 | 328,829 (Indirect Direct) |
View |
| 2024-04-15 Sale |
2024-04-17 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,582 | $59.91 | $1,173,232 | 408,122 (Indirect Direct) |
View |
| 2024-03-15 Sale |
2024-03-18 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $72.48 | $1,449,628 | 427,704 (Indirect Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
14,385 | $77.04 | $1,108,263 | 474,872 (Indirect Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
6,370 | $79.67 | $507,498 | 420,757 (Indirect Direct) |
View |
| 2024-02-15 Sale |
2024-02-16 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $80.36 | $1,607,177 | 426,959 (Indirect Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
50,000 | $60.51 | $3,025,573 | 487,377 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $62.5 | $1,250,058 | 446,959 (Indirect Direct) |
View |
| 2023-05-30 Sale |
2023-06-01 5:44 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $64.88 | $1,621,894 | 466,959 (Direct) |
View |
| 2023-04-25 Sale |
2023-04-27 5:37 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $50.67 | $1,266,638 | 491,959 (Direct) |
View |
| 2023-03-29 Sale |
2023-03-31 5:49 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $44.46 | $1,111,504 | 516,959 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 6:11 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $48.25 | $1,206,243 | 530,570 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 5:34 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $51.47 | $1,286,798 | 548,693 (Direct) |
View |
| 2022-12-28 Sale |
2022-12-30 5:33 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $40.93 | $1,023,290 | 573,693 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-30 5:36 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $54.03 | $1,350,827 | 519,861 (Direct) |
View |
| 2022-10-26 Sale |
2022-10-28 5:43 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $54.81 | $1,370,191 | 558,612 (Direct) |
View |
| 2022-09-28 Sale |
2022-09-30 5:42 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $64.61 | $1,615,160 | 323,612 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-20 Exercise |
2025-03-24 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,688 | $0 | 339,769 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-18 5:35 pm |
N/A 2035-03-14 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
192,500 | $0 | 192,500 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 7:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
28,250 | $0 | 309,550 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-19 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,250 | $0 | 288,845 (Direct) |
View |
| 2024-12-24 Exercise |
2024-12-27 5:35 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,751 | $0 | 280,913 (Direct) |
View |
| 2024-12-24 Exercise |
2024-12-27 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,751 | $16.21 | 280,913 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 5:35 pm |
N/A 2034-10-16 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
455,000 | $0 | 455,000 (Direct) |
View |
| 2024-10-13 Exercise |
2024-10-15 6:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
8,333 | $0 | 328,829 (Direct) |
View |
Ownership |
2024-09-06 5:06 pm |
N/A 2034-03-22 |
Oruka Therapeutics Inc. | ORKA | Kulkarni Samarth Director |
0 | $0 | 199,992 (Direct) |
View |
| 2024-08-08 Gift |
2024-08-12 6:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
100,000 | $0 | 308,122 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 4:32 pm |
N/A 2034-06-25 |
Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
27,200 | $0 | 27,200 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-06 5:55 pm |
N/A 2034-06-05 |
Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director |
30,550 | $0 | 30,550 (Direct) |
View |
| 2024-04-15 Exercise |
2024-04-17 5:45 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,582 | $0 | 408,122 (Direct) |
View |
| 2024-04-15 Exercise |
2024-04-17 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,582 | $19.12 | 408,122 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-22 5:45 pm |
N/A 2034-03-20 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
183,750 | $0 | 183,750 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-18 5:45 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $0 | 427,704 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-18 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $19.12 | 427,704 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-12 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
28,250 | $0 | 474,872 (Direct) |
View |
| 2024-02-18 Exercise |
2024-02-21 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,250 | $0 | 420,757 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:45 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $0 | 426,959 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $19.12 | 426,959 (Direct) |
View |
| 2024-01-29 Exercise |
2024-01-31 5:45 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
50,000 | $0 | 487,377 (Direct) |
View |
| 2024-01-29 Exercise |
2024-01-31 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
50,000 | $19.12 | 487,377 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 5:45 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $0 | 446,959 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $19.12 | 446,959 (Direct) |
View |
| 2023-10-13 Option Award |
2023-10-17 5:51 pm |
N/A 2033-10-13 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
77,500 | $0 | 77,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 5:07 pm |
N/A 2033-06-22 |
Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:25 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
27,200 | $0 | 27,200 (Direct) |
View |
| 2023-05-30 Exercise |
2023-06-01 5:44 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 466,959 (Direct) |
View |
| 2023-05-30 Exercise |
2023-06-01 5:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 466,959 (Direct) |
View |
| 2023-05-16 Option Award |
2023-05-17 9:08 pm |
N/A 2033-05-15 |
Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2023-04-25 Exercise |
2023-04-27 5:37 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 491,959 (Direct) |
View |
| 2023-04-25 Exercise |
2023-04-27 5:37 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 491,959 (Direct) |
View |
| 2023-03-29 Exercise |
2023-03-31 5:49 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 516,959 (Direct) |
View |
| 2023-03-29 Exercise |
2023-03-31 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 516,959 (Direct) |
View |
| 2023-03-13 Tax Withholding |
2023-03-14 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
9,444 | $43.22 | 670,377 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,833 | $0 | 670,377 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 5:47 pm |
N/A 2033-03-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
265,000 | $0 | 670,377 (Direct) |
View |
| 2023-02-27 Exercise |
2023-03-01 6:11 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 530,570 (Direct) |
View |
| 2023-02-27 Exercise |
2023-03-01 6:11 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 530,570 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,250 | $0 | 415,738 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
6,373 | $48.26 | 415,738 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-31 5:34 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 548,693 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-31 5:34 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 548,693 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:33 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 573,693 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 573,693 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
58,233 | $1.81 | 369,111 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 5:35 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
58,233 | $0 | 369,111 (Direct) |
View |
| 2022-12-05 Tax Withholding |
2022-12-06 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,401 | $52.26 | 310,878 (Direct) |
View |
| 2022-12-03 Exercise |
2022-12-06 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
40,000 | $0 | 310,878 (Direct) |
View |
| 2022-11-28 Exercise |
2022-11-30 5:36 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 519,861 (Direct) |
View |
| 2022-11-28 Exercise |
2022-11-30 5:36 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 519,861 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 558,612 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,418 | $19.12 | 558,612 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,582 | $16.21 | 558,612 (Direct) |
View |
| 2022-09-28 Exercise |
2022-09-30 5:42 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 323,612 (Direct) |
View |
| 2022-09-28 Exercise |
2022-09-30 5:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $16.21 | 323,612 (Direct) |
View |